Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024)
Baxter International (BAX) reported Income from Non-Controlling Interests of -$9.0 million for Q4 2024, down 1000.0% year-over-year from $1.0 million in Q1 2024, and down 325.0% on a QoQ basis from $4.0 million in Q3 2024.
Baxter International (BAX) has 9 years of Income from Non-Controlling Interests data on file, last reported at -$9.0 million in Q4 2024.
- Quarterly Income from Non-Controlling Interests fell 1000.0% year-over-year to -$9.0 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$9.0 million (down 190.0% YoY) and the FY2023 annual result came in at $7.0 million, down 41.67% from the prior year.
- Income from Non-Controlling Interests eased to -$9.0 million in Q4 2024 per BAX's latest filing, from $4.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q4 2021 and bottomed at -$9.0 million in Q4 2024.
- The 5-year median for Income from Non-Controlling Interests is $2.5 million (2020), against an average of $1.9 million.
- The widest annual swing landed in 2021, when Income from Non-Controlling Interests surged 200.0%; it then plunged 1000.0% in 2024.
- Tracing BAX's Income from Non-Controlling Interests over 5 years: stood at $3.0 million in 2020, then jumped by 33.33% to $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then tumbled by 75.0% to $1.0 million in 2023, then sank by 1000.0% to -$9.0 million in 2024.
- Per Business Quant, the three latest BAX Income from Non-Controlling Interests figures stand at -$9.0 million (Q4 2024), $4.0 million (Q3 2024), and $3.0 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 89,000.00 |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Dec 31, 2019 | 4.00 Mn |
| Sep 30, 2019 | 6.00 Mn |
| Dec 31, 2011 | 9.00 Mn |
| Sep 30, 2011 | 2.00 Mn |
| Jun 30, 2011 | 10.00 Mn |
| Mar 31, 2011 | 8.00 Mn |
| Dec 31, 2010 | 3.00 Mn |
| Sep 30, 2010 | -1.00 Mn |
| Jun 30, 2010 | 2.00 Mn |
| Mar 31, 2010 | 3.00 Mn |
| Dec 31, 2009 | -19.00 Mn |
| Sep 30, 2009 | 2.00 Mn |
| Jun 30, 2009 | 2.00 Mn |
| Mar 31, 2009 | 2.00 Mn |